Disease Overview：Parkinson's disease（PD）
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to motor symptoms including bradykinesia, resting tremor, rigidity, and postural instability. Non-motor manifestations—such as hyposmia, REM sleep behavior disorder, constipation, depression, and cognitive decline—are increasingly recognized as early and integral components of the disease spectrum. Diagnosis remains clinical, supported by DaT-SPECT imaging or advanced MRI techniques when atypical features arise. While no disease-modifying therapy currently exists, symptomatic management relies on levodopa/carbidopa, dopamine agonists, MAO-B inhibitors, and, in advanced stages, deep brain stimulation (DBS) or continuous subcutaneous apomorphine infusion. Early and individualized intervention significantly improves functional independence and quality of life.
China offers compelling advantages for PD care: its top-tier neurology centers—many affiliated with Peking University Health Science Center, Fudan University Shanghai Medical College, and Sun Yat-sen University—host internationally trained movement disorder specialists and perform over 2,000 DBS procedures annually using next-generation directional leads and intraoperative neurophysiological mapping. Clinical outcomes align with global benchmarks: >85% of DBS recipients report ≥50% improvement in UPDRS-III scores at one year. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising regulatory standards—Chinese Class III medical devices undergo rigorous NMPA certification, and hospitals maintain JCI or CAP accreditation where applicable. As your dedicated medical tourism partner, we streamline international access: verifying physician credentials, coordinating pre-arrival diagnostics, securing priority appointments at accredited centers, providing bilingual clinical liaisons, and delivering itemized, all-inclusive pricing—ensuring transparency from consultation through rehabilitation support.
Parkinson's disease: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Parkinson’s Disease (Neurology Department)
Non-Surgical / Conservative Management
*Target criteria*: Early–moderate idiopathic PD (Hoehn & Yahr stages 1–3), preserved cognition, no significant orthostatic hypotension or psychosis.
- •Levodopa/Carbidopa (immediate-release)
- •Dopamine agonists (e.g., pramipexole, ropinirole)
- •MAO-B inhibitors (selegiline, rasagiline)
- •COMT inhibitors (entacapone, opicapone) — *adj - Monthly cost: $48–$85
- •Neurological evaluation & titration visits (per visit): $45–$75
- •Baseline, renal panel, LFTs, vitamin B12 — $32–$58
- •Quantitative motor assessment (UPDRS-III scoring + video analysis): $65–$95
Surgical / Interventional Options
*Eligibility*: Idiopathic PD ≥4 years duration, clear levodopa response (>30% UPDRS-III improvement), Hoehn & Yahr 3–4, no dementia (MMSE ≥26), no uncontrolled psychiatric illness, MRI brain without contraindications.
- •Deep Brain Stimulation (DBS) — bilateral STN or GPi target
- DBS implantation (surgery + intraoperative microelectrode recording + test stimulation):
$22,500–$31,800 - IPG (implantable pulse generator) device cost (domestic vs. imported): $4,200–$8,900 - Post-op programming (3 sessions over 6 months): $380–$620- •
- Procedure (Exablate® Neuro system):
$18,600–$24,300 - 30-day follow-up neurology visits: $140–$230Special / Complex Condition Management
- •
Quick Selection Guide
- •
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Parkinson's disease Medical Vacation Packages
Curated transparent all-inclusive packages combining Parkinson's disease treatment with China top medical destinations:
